Arctic Bioscience Investor Relations Material
Latest events
Study Result
Arctic Bioscience
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Arctic Bioscience
Access all reports
Arctic Bioscience ASA is a biotechnology company specializing in the development and production of health products derived from marine ingredients, particularly omega-3 fatty acids from herring roe. The company's products are used in the nutraceutical and pharmaceutical sectors, offering health benefits related to brain, heart, and immune function. In addition to producing omega-3-based supplements for consumer markets, Arctic Bioscience is involved in the research and development of new pharmaceutical applications utilizing marine-based bioactive compounds. The company is headquartered in Ørsta, Norway, and its shares are listed on the Oslo Stock Exchange.
Key slides for Arctic Bioscience
Q4 2024
Arctic Bioscience
Q4 2024
Arctic Bioscience
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
ABS
Country
🇳🇴 Norway